Clinical, Immunological, and Molecular Heterogeneity of 173 Patients With the Phenotype of Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked (IPEX) Syndrome
Eleonora Gambineri(Meyer Children's Hospital), Troy R. Torgerson(Allen Institute for Immunology), Eric J. Allenspach(Center for Infectious Disease Research), Marina Vignoli(University of Florence), David Hagin(University of Washington), Hans D. Ochs(University of Washington Medical Center), Stacey DeBoer(University of Washington), Gesmar Rodrigues Silva Segundo(University of Washington), Claudio Favre(Meyer Children's Hospital), Stephanie Añover-Sombke(University of Washington), Sara Ciullini Mannurita(Meyer Children's Hospital)
Cited by 186
Related Papers
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
|Nature Genetics|2001|3.4k
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
|Medicine|2000|1.7k
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
|New England Journal of Medicine|2014|889
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome
|Cell|1993|824
X-Linked Agammaglobulinemia
|Medicine|2006|637